<!DOCTYPE html><html lang="en-us" >

<head>

  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="generator" content="Source Themes Academic 4.8.0">

  

  
  
  
  
  
  

  

  
  
  
    
  
  <meta name="description" content="BRCA1 DNA repair associated
Gene Context Sentence Table 2. Analysis of context sentence of BRCA1 gene in 54 abstracts.   PMID  Gene Context Sentence      21874000  We discovered germline mutations in the gene encoding BRCA1 associated protein-1 (BAP1) in two families with a high incidence of mesothelioma, and we observed somatic alterations affecting BAP1 in familial mesotheliomas, indicating biallelic inactivation.">

  
  <link rel="alternate" hreflang="en-us" href="/mesothelioma/genepanel/672/gene_context/">

  


  
  
  
  <meta name="theme-color" content="#2962ff">
  

  
  

  
  
  
  
    
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/academicons/1.8.6/css/academicons.min.css" integrity="sha256-uFVgMKfistnJAfoCUQigIl+JfUaP47GrRKjf6CTPVmw=" crossorigin="anonymous">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.0-1/css/all.min.css" integrity="sha256-4w9DunooKSr3MFXHXWyFER38WmPdm361bQS/2KUWZbU=" crossorigin="anonymous">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.5.7/jquery.fancybox.min.css" integrity="sha256-Vzbj7sDDS/woiFS3uNKo8eIuni59rjyNGtXfstRzStA=" crossorigin="anonymous">

    
    
    
      
    
    
      
      
        
          <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.18.1/styles/github.min.css" crossorigin="anonymous" title="hl-light">
          <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.18.1/styles/dracula.min.css" crossorigin="anonymous" title="hl-dark" disabled>
        
      
    

    

    

    
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
        <script src="https://cdnjs.cloudflare.com/ajax/libs/lazysizes/5.1.2/lazysizes.min.js" integrity="sha256-Md1qLToewPeKjfAHU1zyPwOutccPAm5tahnaw7Osw0A=" crossorigin="anonymous" async></script>
      
    
      

      
      

      
    
      

      
      

      
    
      

      
      
        
      

      
    
      

      
      

      
    

  

  
  
  
  <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Montserrat:400,700%7CRoboto:400,400italic,700%7CRoboto+Mono&display=swap">
  

  
  
  
  
  <link rel="stylesheet" href="/mesothelioma/css/academic.css">

  





<script async src="https://www.googletagmanager.com/gtag/js?id=google_analytics_ID"></script>
<script>
  window.dataLayer = window.dataLayer || [];

  function gtag() {
      dataLayer.push(arguments);
  }

  function trackOutboundLink(url, target) {
    gtag('event', 'click', {
         'event_category': 'outbound',
         'event_label': url,
         'transport_type': 'beacon',
         'event_callback': function () {
           if (target !== '_blank') {
             document.location = url;
           }
         }
    });
    console.debug("Outbound link clicked: " + url);
  }

  function onClickCallback(event) {
    if ((event.target.tagName !== 'A') || (event.target.host === window.location.host)) {
      return;
    }
    trackOutboundLink(event.target, event.target.getAttribute('target'));  
  }

  gtag('js', new Date());
  gtag('config', 'google_analytics_ID', {});

  
  document.addEventListener('click', onClickCallback, false);
</script>


  


  
  

  

  <link rel="manifest" href="/mesothelioma/index.webmanifest">
  <link rel="icon" type="image/png" href="/mesothelioma/images/icon_hu7e12209333f22d741aca7d462871821f_9877_32x32_fill_lanczos_center_2.png">
  <link rel="apple-touch-icon" type="image/png" href="/mesothelioma/images/icon_hu7e12209333f22d741aca7d462871821f_9877_192x192_fill_lanczos_center_2.png">

  <link rel="canonical" href="/mesothelioma/genepanel/672/gene_context/">

  
  
  
  
  
  
  
    
    
  
  
  <meta property="twitter:card" content="summary">
  
  <meta property="og:site_name" content="mesothelioma">
  <meta property="og:url" content="/mesothelioma/genepanel/672/gene_context/">
  <meta property="og:title" content="BRCA1 | mesothelioma">
  <meta property="og:description" content="BRCA1 DNA repair associated
Gene Context Sentence Table 2. Analysis of context sentence of BRCA1 gene in 54 abstracts.   PMID  Gene Context Sentence      21874000  We discovered germline mutations in the gene encoding BRCA1 associated protein-1 (BAP1) in two families with a high incidence of mesothelioma, and we observed somatic alterations affecting BAP1 in familial mesotheliomas, indicating biallelic inactivation."><meta property="og:image" content="/mesothelioma/images/icon_hu7e12209333f22d741aca7d462871821f_9877_512x512_fill_lanczos_center_2.png">
  <meta property="twitter:image" content="/mesothelioma/images/icon_hu7e12209333f22d741aca7d462871821f_9877_512x512_fill_lanczos_center_2.png"><meta property="og:locale" content="en-us">
  
    
      <meta property="article:published_time" content="2019-05-05T00:00:00&#43;01:00">
    
    <meta property="article:modified_time" content="2019-05-05T00:00:00&#43;01:00">
  

  



  


  


  





  <title>BRCA1 | mesothelioma</title>

</head>

<body id="top" data-spy="scroll" data-offset="70" data-target="#TableOfContents" >

  <aside class="search-results" id="search">
  <div class="container">
    <section class="search-header">

      <div class="row no-gutters justify-content-between mb-3">
        <div class="col-6">
          <h1>Search</h1>
        </div>
        <div class="col-6 col-search-close">
          <a class="js-search" href="#"><i class="fas fa-times-circle text-muted" aria-hidden="true"></i></a>
        </div>
      </div>

      <div id="search-box">
        
        <input name="q" id="search-query" placeholder="Search..." autocapitalize="off"
        autocomplete="off" autocorrect="off" spellcheck="false" type="search">
        
      </div>

    </section>
    <section class="section-search-results">

      <div id="search-hits">
        
      </div>

    </section>
  </div>
</aside>


  







<nav class="navbar navbar-expand-lg navbar-light compensate-for-scrollbar" id="navbar-main">
  <div class="container">

    
    <div class="d-none d-lg-inline-flex">
      <a class="navbar-brand" href="/mesothelioma/">mesothelioma</a>
    </div>
    

    
    <button type="button" class="navbar-toggler" data-toggle="collapse"
            data-target="#navbar-content" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
    <span><i class="fas fa-bars"></i></span>
    </button>
    

    
    <div class="navbar-brand-mobile-wrapper d-inline-flex d-lg-none">
      <a class="navbar-brand" href="/mesothelioma/">mesothelioma</a>
    </div>
    

    
    
    <div class="navbar-collapse main-menu-item collapse justify-content-start" id="navbar-content">

      
      <ul class="navbar-nav d-md-inline-flex">
        

        

        
        
        
          
        

        
        
        
        
        
        

        <li class="nav-item">
          <a class="nav-link " href="/mesothelioma/syntax/"><span>Syntax</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        

        <li class="nav-item">
          <a class="nav-link  active" href="/mesothelioma/genepanel/"><span>Gene Panel</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        

        <li class="nav-item">
          <a class="nav-link " href="/mesothelioma/drugpanel/"><span>Drug Panel</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        

        <li class="nav-item">
          <a class="nav-link " href="/mesothelioma/tissuepanel/"><span>Tissue Panel</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        

        <li class="nav-item">
          <a class="nav-link " href="/mesothelioma/syntax_summary/"><span>Literature Consensus</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        
          
          
          
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/mesothelioma/#about"><span>Contact</span></a>
        </li>

        
        

      

        
      </ul>
    </div>

    <ul class="nav-icons navbar-nav flex-row ml-auto d-flex pl-md-2">
      
      <li class="nav-item">
        <a class="nav-link js-search" href="#"><i class="fas fa-search" aria-hidden="true"></i></a>
      </li>
      

      

      

    </ul>

  </div>
</nav>


  

<div class="container-fluid docs">
  <div class="row flex-xl-nowrap">
    <div class="col-12 col-md-3 col-xl-2 docs-sidebar">
      





  
    
  




<form class="docs-search d-flex align-items-center">
  <button class="btn docs-toggle d-md-none p-0 mr-3" type="button" data-toggle="collapse" data-target="#docs-nav" aria-controls="docs-nav" aria-expanded="false" aria-label="Toggle section navigation">
    <span><i class="fas fa-bars"></i></span>
  </button>

  
  <input name="q" type="search" class="form-control" placeholder="Search..." autocomplete="off">
  
</form>

<nav class="collapse docs-links" id="docs-nav">
  

  
  
  
  
  <div class="docs-toc-item">
    <a class="docs-toc-link" href="/mesothelioma/genepanel/672/info/">Overview</a>
    <ul class="nav docs-sidenav">
      
      <li >
        <a href="/mesothelioma/genepanel/672/gene_expression/">Gene Expression</a>
      </li>
      
      <li class="active">
        <a href="/mesothelioma/genepanel/672/gene_context/">Gene Context</a>
      </li>
      
      <li >
        <a href="/mesothelioma/genepanel/672/clinvar/">ClinVar</a>
      </li>
      
      <li >
        <a href="/mesothelioma/genepanel/672/geo/">Geo DataSet</a>
      </li>
      
    </ul>
    

  </div>
  
  
</nav>

    </div>

    

    <main class="col-12 col-md-9 col-xl-8 py-md-3 pl-md-5 docs-content" role="main">

      <article class="article">

        <div class="docs-article-container">
          <h1>BRCA1</h1>

          <div class="article-style">
            
<script src="/mesotheliomarmarkdown-libs/kePrint/kePrint.js"></script>


<hr />
<p>BRCA1 DNA repair associated</p>
<hr />
<div id="gene-context-sentence" class="section level2">
<h2>Gene Context Sentence</h2>
<br>
<p style="font-size:12px" align="center">
<strong>Table 2.</strong> Analysis of context sentence of BRCA1 gene in 54 abstracts.
</p>
<table class="table table-striped" style="width: auto !important; margin-left: auto; margin-right: auto;">
<thead>
<tr>
<th style="text-align:center;position: sticky; top:0; background-color: #FFFFFF;">
PMID
</th>
<th style="text-align:center;position: sticky; top:0; background-color: #FFFFFF;">
Gene Context Sentence
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:center;">
<a href="/publication/21874000" target="_blank">21874000</a>
</td>
<td style="text-align:center;">
We discovered germline mutations in the gene encoding BRCA1 associated protein-1 (BAP1) in two families with a high incidence of mesothelioma, and we observed somatic alterations affecting BAP1 in familial mesotheliomas, indicating biallelic inactivation.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/22190288" target="_blank">22190288</a>
</td>
<td style="text-align:center;">
BRCA1 regulates sensitivity to microtubule poisons; however, its role in regulating vinorelbine-induced apoptosis in mesothelioma is unknown. […] Here we demonstrate that BRCA1 plays an essential role in mediating vinorelbine-induced apoptosis, as evidenced by (1) the strong correlation between vinorelbine sensitivity and BRCA1 expression level; (2) induction of resistance to vinorelbine by BRCA1 using siRNA oligonucleotides; (3) dramatic down-regulation of BRCA1 following selection for vinorelbine resistance; and (4) the re-activation of vinorelbine-induced apoptosis following re-expression of BRCA1 in resistant cells. […] To determine whether loss of BRCA1 expression in mesothelioma was potentially relevant in vivo, BRCA1 immunohistochemistry was subsequently performed on 144 primary mesothelioma specimens. […] Loss of BRCA1 protein expression was identified in 38.9% of samples. […] Together, these data suggest that BRCA1 plays a critical role in mediating apoptosis by vinorelbine in mesothelioma, warranting its clinical evaluation as a predictive biomarker.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/22960937" target="_blank">22960937</a>
</td>
<td style="text-align:center;">
We investigated the baseline expression and impact on outcome of predictive biomarkers ERCC1, BRCA1, and class III β-tubulin in a cohort of MPM patients treated with cisplatin-vinorelbine. […] Formalin-fixed paraffin-embedded tumor specimens from 54 MPM patients included in a phase II trial were evaluated for ERCC1, BRCA1, and class III β-tubulin by immunohistochemistry (IHC). […] BRCA1 status was associated with neither PFS nor OS.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/23677068" target="_blank">23677068</a>
</td>
<td style="text-align:center;">
The cyclin-dependent kinase inhibitor 2A/alternative reading frame (CDKN2A/ARF), neurofibromatosis type 2 (NF2) and BRCA1-associated protein-1 (BAP1) genes are the most frequently mutated tumor suppressor genes detected in MM cells; the alterations of the latter two are relatively characteristic of MM.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/23833051" target="_blank">23833051</a>
</td>
<td style="text-align:center;">
Recent reports have also focused upon germline mutations in the BRCA1-associated protein 1 (BAP1), not only in cases of familial mesothelioma, but also BAP1 deletion in sporadic MM.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/23963927" target="_blank">23963927</a>
</td>
<td style="text-align:center;">
BRCA1-associated protein 1 (BAP1) is a tumor suppressor gene that is frequently lost in MPM.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/25380601" target="_blank">25380601</a>
</td>
<td style="text-align:center;">
BRCA1-associated protein-1 (BAP1) mutations cause a new cancer syndrome, with a high rate of malignant mesothelioma (MM).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/25468148" target="_blank">25468148</a>
</td>
<td style="text-align:center;">
23% of mesothelioma tumor specimens have a mutation in the BRCA1-associated protein 1 (BAP1) gene and germline BAP1 mutations predispose to malignant pleural mesothelioma (MPM).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/25514803" target="_blank">25514803</a>
</td>
<td style="text-align:center;">
A series of 123 formalin-fixed, paraffin-embedded tissue samples with clinical annotations were retrospectively tested with a commercial library kit (Ion AmpliSeq Cancer Hotspot Panel v.2, Life Technologies, Grand Island, NY) to investigate 50 genes plus other two, BRCA1-associated protein-1 (BAP-1) and neurofibromatosis-2 (NF2), frequently altered in MPM.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/25970771" target="_blank">25970771</a>
</td>
<td style="text-align:center;">
Through an unbiased siRNA screen we found that BRCA1-associated protein 1 (BAP1) regulates their expression, with HDAC2 reduced and HDAC1 increased in BAP1 depleted cells.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/25979846" target="_blank">25979846</a>
</td>
<td style="text-align:center;">
Putative predictive markers for pemetrexed-platinum are tumor TS and TYMS, for vinorelbine the ERCC1, beta-tubuline class III and BRCA1.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/26022455" target="_blank">26022455</a>
</td>
<td style="text-align:center;">
Recently, variants of the BRCA1-associated protein 1 (BAP1) gene resulting in nuclear protein loss were reported in hereditary and sporadic mesothelioma.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/26246155" target="_blank">26246155</a>
</td>
<td style="text-align:center;">
Somatic mutations of BRCA1 associated protein-1 (BAP1) gene were recently found in MM as well as in uveal melanoma and kidney cancer among the Caucasian and Japanese people.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/26288396" target="_blank">26288396</a>
</td>
<td style="text-align:center;">
To briefly review adjunctive tests claimed to be useful in this setting and to examine in detail 2 new tests: p16 fluorescence in situ hybridization (FISH) and BRCA1-associated protein 1 (BAP1) immunohistochemistry.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/26811225" target="_blank">26811225</a>
</td>
<td style="text-align:center;">
The discovery of inactivating mutations in the BRCA1-associated protein 1 gene in sporadic and hereditary mesothelioma has opened up a variety of novel molecular, clinical, and diagnostic investigations.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/26995100" target="_blank">26995100</a>
</td>
<td style="text-align:center;">
The tumor suppressor gene BRCA1 associated protein 1 (BAP1) is involved in several cancers, including MMD.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/27127763" target="_blank">27127763</a>
</td>
<td style="text-align:center;">
Breast cancer susceptibility gene 1 (BRCA1) expression has been suggested as a predictor in anti-neoplastic treatment with anti-microtubule agents. […] Consulting the literature, we sought to examine the true impact of BRCA1 expression on the efficacy of anti-microtubule agents. […] Through meta-analyses, we observed a potentially greater ORR in the population with high BRCA1 expression vs. low BRCA1 expression (OR 1.63, 95% CI: 0.92 to 2.88, P=0.09) but the heterogeneity is severe (P=0.01; I(2)=61%). […] After stratification by testing methods, a significantly higher ORR in the population with high BRCA1 expression was shown in the subgroup using mRNA as a quantitative method (OR 2.90, 95% CI: 1.92 to 4.39, P&lt;0.01; I(2)=0) whereas the difference in the subgroup using immunohistochemistry (IHC) was not significant (OR 0.60, 95% CI: 0.33 to 1.10, P=0.10; I(2)=0). […] Although the predictive value of BRCA1 expression on the anti-microtubule chemotherapy remained uncertain based on overall results, our exploratory analyses suggested that detection using mRNA might be a preferred technique, however, further validation is required to substantiate our findings.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/27282309" target="_blank">27282309</a>
</td>
<td style="text-align:center;">
The first studies reporting on the genomic background of MPM identified recurrent somatic mutations in a number of tumor suppressor genes (i.e., cyclin-dependent kinase inhibitor 2A gene [CDKN2A], neurofibromin 2 (merlin) gene [NF2], and BRCA1 associated protein 1 gene [BAP1]).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/27422796" target="_blank">27422796</a>
</td>
<td style="text-align:center;">
Recent data identified BRCA1-associated protein 1 gene (BAP1) as one of the most frequently mutated genes in MPM. […] Immunohistochemical testing for BRCA1-associated protein 1 (BAP1) has been proposed to be predictive for the detection of BAP1 mutation in neoplastic cells.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/27447750" target="_blank">27447750</a>
</td>
<td style="text-align:center;">
However, in about 10-20% of the cases, the IHC results can be confusing and inconclusive, and novel markers are sought to increase the diagnostic accuracy.We stained 45 non-small cell lung cancer samples (32 adenocarcinomas and 13 squamous cell carcinomas) with a monoclonal antibody for BRCA1-associated protein 1 (BAP1) and also with an IHC panel we routinely use to help differentiate MM from carcinomas, which include, calretinin, Wilms Tumor 1, cytokeratin 5, podoplanin D2-40, pankeratin CAM5.2, thyroid transcription factor 1, Napsin-A, and p63.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/27507853" target="_blank">27507853</a>
</td>
<td style="text-align:center;">
The most common aberrations were in BAP1 (BRCA1-associated protein 1; 47.6% [20/42]), NF2 (38.1% [16/42]), and CDKN2A/B (loss) (35.7% [15/42]).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/27614970" target="_blank">27614970</a>
</td>
<td style="text-align:center;">
Loss of nuclear staining of BRCA1-associated protein 1 (BAP1; detected using immunohistochemistry (IHC)) and homozygous deletion (HD) of p16 (detected using fluorescence in situ hybridization (FISH)) are useful for differentiation of MPM from reactive mesothelial hyperplasia (RMH), but the correlation between BAP1 expression loss and p16 HD has not been fully described.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/27698933" target="_blank">27698933</a>
</td>
<td style="text-align:center;">
All statistical analyses were calculated with the R i386 statistical programming environment. <i>CDC25A</i> and <i>PARP1</i> gene expression were correlated with lymph node spread, <i>BRCA1</i> and <i>TP73</i> expression levels with higher IMIG stage. <i>NTHL1</i> and <i>XRCC3</i> expression was associated with TNM stage. <i>CHECK1</i> as well as <i>XRCC2</i> expression levels were correlated with tumour progression in the overall cohort of patients. <i>CDKN2A</i> and <i>MLH1</i> gene expression influenced overall survival in this collective.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/27984124" target="_blank">27984124</a>
</td>
<td style="text-align:center;">
BRCA1-associated protein 1 (BAP1) is a tumor suppressor gene involved in regulation of the cell cycle, cellular differentiation, repair of DNA damage, and apoptosis.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/28007630" target="_blank">28007630</a>
</td>
<td style="text-align:center;">
BRCA1 associated protein 1 nuclear staining was lost in percentages similar to what has been reported for samples from Western countries.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/28034829" target="_blank">28034829</a>
</td>
<td style="text-align:center;">
BRCA1 associated protein 1 (BAP1) is a deubiquitinating hydrolase that plays a key role in various cellular processes. […] Germline and somatic inactivation of BRCA1 associated protein 1 gene (BAP1) is frequent in pleural mesothelioma; however, little is known about its status in peritoneal mesothelioma.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/28213009" target="_blank">28213009</a>
</td>
<td style="text-align:center;">
Detection of homozygous deletion (HD) of 9p21 region including p16<sup>INK4A</sup> (p16) by fluorescence in situ hybridization (FISH) and immunohistochemical detection of loss of BRCA1 associated protein 1 (BAP1), are reliable markers for MPM diagnosis.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/28389374" target="_blank">28389374</a>
</td>
<td style="text-align:center;">
BRCA1 associated protein1 (BAP1) is a tumor suppressor involved in multiple cellular processes such as transcriptional regulation, chromatin modification by deubiquitinating histone 2A, and DNA repair. […] MPM cell lines expressing more than 20% of BAP1Δ are more sensitive to olaparib (a PARP1 inhibitor) cytotoxicity, and this sensitivity is enhanced when olaparib treatment is combined with GDC0980 (a dual PI3K-mTOR inhibitor), which induces downregulation of BRCA1.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/28687356" target="_blank">28687356</a>
</td>
<td style="text-align:center;">
Ten pathogenic truncating variants (PTVs) were identified in PALB2, BRCA1, FANCI, ATM, SLX4, BRCA2, FANCC, FANCF, PMS1 and XPC.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/28756516" target="_blank">28756516</a>
</td>
<td style="text-align:center;">
BAP1 is a homologous recombination (HR) DNA repair component found in the BRCA1/BARD1 complex. […] Similar to BRCA1/2 deficient cancers, mutation in the BAP1 gene leads to a deficient HR pathway and increases the reliance on other DNA repair pathways. […] We hypothesized that BAP1-mutant MPM would require PARP1 for survival, similar to the BRCA1/2 mutant breast and ovarian cancers.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/29053210" target="_blank">29053210</a>
</td>
<td style="text-align:center;">
Homozygous deletion of 9p21 detected by fluorescence in situ hybridization (FISH) and loss of BRCA1-associated protein 1 (BAP1) expression detected by immunohistochemistry (IHC) are useful for the differentiation between malignant pleural mesothelioma (MPM) and reactive mesothelial hyperplasia.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/29076876" target="_blank">29076876</a>
</td>
<td style="text-align:center;">
Recently, loss of BRCA1-associated protein 1 (BAP1) expression and/or homozygous deletion of CDKN2A were identified in some MM, but not in reactive mesothelial proliferations.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/29206890" target="_blank">29206890</a>
</td>
<td style="text-align:center;">
A high proportion of mesothelioma harbor mutations in the BRCA1-associated protein 1 (BAP1) gene.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/29266978" target="_blank">29266978</a>
</td>
<td style="text-align:center;">
The prognostic value of BRCA1-associated protein 1 (BAP1) expression in different cancer types remains controversial.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/29350783" target="_blank">29350783</a>
</td>
<td style="text-align:center;">
However, these cells had lost BRCA1-associated protein 1 (BAP1) and showed loss of cyclin-dependent kinase inhibitor 2 (CDKN2A) (p16) by fluorescence in-situ hybridisation (FISH).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/29480760" target="_blank">29480760</a>
</td>
<td style="text-align:center;">
A small number of mesotheliomas (probably in the order of 1%) are caused by germline mutations/deletions of BRCA1-associated protein-1 ( BAP1) in kindreds that also develop a variety of other cancers.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/29507796" target="_blank">29507796</a>
</td>
<td style="text-align:center;">
Moreover, in challenging cases, fluorescent in situ hybridization (FISH) testing for the <i>p16</i> deletion and IHC to evaluate the loss of BRCA1-associated protein 1 (BAP1) expression could be useful in distinguishing benign from malignant pleural proliferations.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/29524617" target="_blank">29524617</a>
</td>
<td style="text-align:center;">
Whereas recent epidemiological data demonstrated that the incidence of MPM-related death continued to increase in United States between 2009 and 2015, new insight into the molecular pathogenesis and the immunological tumor microenvironment of MPM, for example, regarding the role of BRCA1 associated protein 1 and the expression programmed death receptor ligand 1, are highlighting new potential therapeutic strategies. […] In addition, other promising targeted therapies, including pegylated adenosine deiminase (ADI-PEG20), which focuses on argininosuccinate synthase 1-deficient tumors, and tazemetostat, an enhancer of zeste 2 polycomb repressive complex 2 subunit inhibitor of BRCA1 associated protein 1 gene (BAP1)-deficient tumors, are currently being explored.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/29891518" target="_blank">29891518</a>
</td>
<td style="text-align:center;">
Collectively, these data led to the diagnosis of <i>BAP1</i> (<i>BRCA1</i>-associated protein-1) tumor predisposition syndrome (TPDS).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/29904909" target="_blank">29904909</a>
</td>
<td style="text-align:center;">
The most frequently altered genes in human MM are cyclin-dependent kinase inhibitor 2A (CDKN2A), which encodes components of the p53 (p14ARF) and RB (p16INK4A) pathways, BRCA1-associated protein 1 (BAP1), and neurofibromatosis 2 (NF2).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/30156768" target="_blank">30156768</a>
</td>
<td style="text-align:center;">
The differentiation of reactive mesothelial cells from malignant mesothelioma and adenocarcinoma is a recurring theme, and Wilms tumor 1 (WT1)/AE1/AE3, claudin 4, and BRCA1-associated protein 1 (BAP1) immunostains are useful new tools in the armamentarium.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/30402386" target="_blank">30402386</a>
</td>
<td style="text-align:center;">
Due to concern for MPM, ancillary testing was obtained - loss of BRCA1 associated protein (BAP-1) and <i>CDKN2A/p16</i> gene deletion.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/30429020" target="_blank">30429020</a>
</td>
<td style="text-align:center;">
Loss of BRCA1-associated protein 1 (BAP1) expression as detected by immunohistochemistry (IHC) (BAP1 IHC) and homozygous deletion (HD) of 9p21 as detected by fluorescencein situ hybridization (FISH) (9p21 FISH) are effective for distinguishing malignant mesothelial proliferation from benign proliferation.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/30520251" target="_blank">30520251</a>
</td>
<td style="text-align:center;">
The newly appreciated BRCA1-associated protein 1 (BAP1) antibody may help distinguish MM from RMC based on its immunohistochemical (IHC) staining pattern but its role in cytopathology is controversial.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/30810450" target="_blank">30810450</a>
</td>
<td style="text-align:center;">
BAP-1 is a BRCA1-binding protein whose loss of expression was frequently reported in MPM.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/31165505" target="_blank">31165505</a>
</td>
<td style="text-align:center;">
The aim of this study was to investigate the utility of BRCA1-associated protein-1 (BAP1), glucose transporter (GLUT)-1 and desmin expression by immunohistochemistry in the discrimination between reactive and malignant mesothelial proliferations.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/31169558" target="_blank">31169558</a>
</td>
<td style="text-align:center;">
Identification of BRCA1-associated protein 1 (BAP1) and cyclin-dependent kinase inhibitor 2A (CDKN2A) gene mutations in MPM have led to the development of new ancillary tests that can streamline the diagnostic pathway.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/31580004" target="_blank">31580004</a>
</td>
<td style="text-align:center;">
In this study, we investigated whether MPM cells with BRCA1-associated protein 1 (BAP1) loss show the same morphological characteristics identified in MPM cells with 9p21 HD.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/31619462" target="_blank">31619462</a>
</td>
<td style="text-align:center;">
Loss of function of BRCA1-associated protein 1 (BAP1) is observed in about 50% of malignant pleural mesothelioma (MPM) cases.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/31897219" target="_blank">31897219</a>
</td>
<td style="text-align:center;">
Among investigated markers, the loss of BRCA1 associated protein 1 (BAP1) protein expression and the homozygous deletion of <i>p16</i> have shown 100% specificity in separating benign and malignant mesothelial lesions.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32036091" target="_blank">32036091</a>
</td>
<td style="text-align:center;">
Currently, BRCA1-associated protein 1 (BAP1) and CDKN2A (p16), evaluated by immunohistochemistry and fluorescent in situ hybridization, respectively, are the most valuable markers to discriminate MPM and MH.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32175161" target="_blank">32175161</a>
</td>
<td style="text-align:center;">
The BRCA1, BRCA2, CDK7, MLH3, MSH4, NEIL3, SMUG1, UNG, XRCC2, and XRCC4 genes showed more than five-fold higher expression in the patients with lung adenocarcinomas, compared to the control group. […] The patients with malignant pleural mesothelioma showed a five-fold higher expression in the APEX2, BRCA1, BRCA2, CDK7, MLH1, MLH3, MSH3, MSH4, NEIL3, PARP2, PARP3, PMS1, RAD50, RAD51, RAD51B, RAD51D, RAD52, RPA3, SMUG1, UNG, XPA, XRCC2, and XRCC4 genes, compared to the control group.
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32542810" target="_blank">32542810</a>
</td>
<td style="text-align:center;">
BRCA1-associated protein 1 (BAP1) or methylthioadenosine phosphorylase (MTAP) immunohistochemistry (IHC) or 9p21 fluorescence in situ hybridization (FISH) are useful for the diagnosis of malignant pleural mesothelioma (MPM).
</td>
</tr>
<tr>
<td style="text-align:center;">
<a href="/publication/32622302" target="_blank">32622302</a>
</td>
<td style="text-align:center;">
The prognostic role of BRCA1 associated protein-1 (BAP1) expression in malignant pleural mesothelioma (MPM) is a matter of debate.
</td>
</tr>
</tbody>
</table>
<hr />
</div>

          </div>

          



          
        </div>

        <div class="body-footer">
          
          

          
        </div>

      </article>

      <footer class="site-footer">
  
  <p class="powered-by">
    
      <a href="/mesothelioma/privacy/">Privacy Policy</a>
    
    
        &middot; 
      <a href="/mesothelioma/terms/">Terms</a>
    
    
        &middot; 
      <a href="/mesothelioma/supp/faq/">FAQ</a>
    
  </p>
  

  <p class="powered-by">
    BioHub - UFPE &middot; 

    Powered by the
    <a href="https://sourcethemes.com/academic/" target="_blank" rel="noopener">Academic theme</a> for
    <a href="https://gohugo.io" target="_blank" rel="noopener">Hugo</a>.

    
  </p>
</footer>


    </main>
  </div>
</div>


      

    
    
    
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.4.1/jquery.min.js" integrity="sha256-CSXorXvZcTkaix6Yvo6HppcZGetbYMGWSFlBw8HfCJo=" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.imagesloaded/4.1.4/imagesloaded.pkgd.min.js" integrity="sha256-lqvxZrPLtfffUl2G/e7szqSvPBILGbwmsGE1MKlOi0Q=" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.isotope/3.0.6/isotope.pkgd.min.js" integrity="sha256-CBrpuqrMhXwcLLUd5tvQ4euBHCdh7wGlDfNz8vbu/iI=" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.5.7/jquery.fancybox.min.js" integrity="sha256-yt2kYMy0w8AbtF89WXb2P1rfjcP/HTHLT7097U8Y5b8=" crossorigin="anonymous"></script>

      

      
        
        <script src="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.18.1/highlight.min.js" integrity="sha256-eOgo0OtLL4cdq7RdwRUiGKLX9XsIJ7nGhWEKbohmVAQ=" crossorigin="anonymous"></script>
        
        <script src="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.18.1/languages/r.min.js"></script>
        
      

    

    
    

    
    
    <script>const code_highlighting = true;</script>
    

    
    
    <script>const isSiteThemeDark = false;</script>
    

    
    
    
    
    
    
    <script>
      const search_config = {"indexURI":"/mesothelioma/index.json","minLength":1,"threshold":0.3};
      const i18n = {"no_results":"No results found","placeholder":"Search...","results":"results found"};
      const content_type = {
        'post': "Posts",
        'project': "Projects",
        'publication' : "Publications",
        'talk' : "Talks"
        };
    </script>
    

    
    
    <script src="https://cdnjs.cloudflare.com/ajax/libs/anchor-js/4.1.1/anchor.min.js" integrity="sha256-pB/deHc9CGfFpJRjC43imB29Rse8tak+5eXqntO94ck=" crossorigin="anonymous"></script>
    <script>
      anchors.add();
    </script>
    

    
    
    <script id="search-hit-fuse-template" type="text/x-template">
      <div class="search-hit" id="summary-{{key}}">
      <div class="search-hit-content">
        <div class="search-hit-name">
          <a href="{{relpermalink}}">{{title}}</a>
          <div class="article-metadata search-hit-type">{{type}}</div>
          <p class="search-hit-description">{{snippet}}</p>
        </div>
      </div>
      </div>
    </script>
    

    
    
    <script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/3.2.1/fuse.min.js" integrity="sha256-VzgmKYmhsGNNN4Ph1kMW+BjoYJM2jV5i4IlFoeZA9XI=" crossorigin="anonymous"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/jquery.mark.min.js" integrity="sha256-4HLtjeVgH0eIB3aZ9mLYF6E8oU5chNdjU6p6rrXpl9U=" crossorigin="anonymous"></script>
    

    
    

    
    

    
    
    <script id="dsq-count-scr" src="https://procovid19.disqus.com/count.js" async></script>
    

    
    
    
    
    
    
    
    
    
      
    
    
    
    
    <script src="/mesothelioma/js/academic.min.37431be2d92d7fb0160054761ab79602.js"></script>

    






  
  

  
<div id="modal" class="modal fade" role="dialog">
  <div class="modal-dialog">
    <div class="modal-content">
      <div class="modal-header">
        <h5 class="modal-title">Cite</h5>
        <button type="button" class="close" data-dismiss="modal" aria-label="Close">
          <span aria-hidden="true">&times;</span>
        </button>
      </div>
      <div class="modal-body">
        <pre><code class="tex hljs"></code></pre>
      </div>
      <div class="modal-footer">
        <a class="btn btn-outline-primary my-1 js-copy-cite" href="#" target="_blank">
          <i class="fas fa-copy"></i> Copy
        </a>
        <a class="btn btn-outline-primary my-1 js-download-cite" href="#" target="_blank">
          <i class="fas fa-download"></i> Download
        </a>
        <div id="modal-error"></div>
      </div>
    </div>
  </div>
</div>

</body>
</html>
